Billiontoone Menlo Park , CA 94026
Posted 3 weeks ago
BillionToOne, is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. The company's innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over 1,000-fold. This groundbreaking technology is integral to BillionToOne's product offerings. One of BillionToOne's flagship products, Unity Complete, is the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, BillionToOne is expanding its reach into oncology with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. Over 500K patients have received BillionToOne tests to date, and BillionToOne has grown from $0M to $125M ARR in the last ~4 years.
Ranked at the top 5% of Y Combinator companies, BillionToOne has successfully raised close to $400 million in funding to date, with a notable $130 million Series D round completed in June 2024, resulting in an company evaluation of over $1 billion. This funding has come from prestigious global institutional investors, including Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.
BillionToOne's team has grown significantly and now proudly employs over 400 highly skilled individuals. Despite substantial growth, BillionToOne has successfully maintained the unique culture that defined us from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Northstar product and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit the company's website at www.billiontoone.com.
We are looking for a Senior Bioinformatics Scientist to create computational tools and analyze ground-breaking molecular diagnostics data. This person will be responsible for the generation, analysis, and communication of clinical next-generation DNA sequencing data for the prenatal Unity Complete product. Our sample volume is growing extremely quickly, and this role will own the further development of our analysis pipeline to analyze tens of thousands of samples, as well as being the lead scientist for everything related to our bioinformatics analyses. The Senior Bioinformatics Scientist role is a full-time onsite position in our Menlo Park office.
Responsibilities:
Requirements:
Nice-To-Haves:
Benefits And Perks:
At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based on experience and salary/equity options split that the candidate chooses) (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid paternal leave etc.).
For this position, the base pay range is: $150,000-$170,000 per year.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Billiontoone